+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

ASEAN Rabies Veterinary Vaccines Market Size, Share & Trends Analysis Report By Application (Companion Animals, Livestock Animals), By Country, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 80 Pages
  • December 2022
  • Region: Asia Pacific
  • Grand View Research
  • ID: 5712478

The ASEAN rabies veterinary vaccines market size is expected to reach USD 41.01 million by 2030. The market is expected to expand at a CAGR of 5.82% from 2023 to 2030. The market is primarily driven by growing rabies vaccination coverage among dogs in ASEAN countries, rising awareness regarding zoonotic diseases, and increasing government initiatives to eradicate animal and human rabies by the end of 2030.



Appropriate management of the disease in domestic dog populations is essential for the prevention of rabies in humans. The majority of documented rabies cases in both animals and humans of ASEAN countries are caused by dogs. To effectively prevent and control both animal and human rabies, it is vital to raise public awareness regarding the disease while also encouraging responsible pet ownership and animal welfare. Technical and socio-cultural frameworks should both be taken into consideration in a rabies control program. Technical aspects consist of dog population management, vaccination programs, adequate diagnostic capability, disease surveillance programs, and animal movement control. The socio-cultural factors include educating the public and advocating ethical pet ownership and animal welfare.

FAO, OIE, WHO, and the Global Alliance for Rabies Control (GARC) established a collaborative framework called "United Against Rabies" to achieve zero human rabies death by 2030”, referred from secondary source published by WHO.

In ASEAN countries, rabies is a serious public health concern. It has significant adverse effects on human health, the economy, and animal welfare. The primary reservoir and transmitter of rabies in the region are domestic dogs. Lack of funding, a lack of political commitment to rabies control initiatives, a lack of agreement on a strategy, weak intersectoral coordination, insensitive surveillance systems, an inadequate management structure, limited access to modern rabies vaccines, supply issues, a lack of public awareness and cooperation, myths, and religious concerns are all key challenges to rabies control programs. Most ASEAN nations have an endemic canine rabies issue. However, widespread immunization can reduce disease in the dog population. The majority of policy and decision-making is done at the national level, therefore developing, and implementing rabies management policies can benefit from a thorough understanding of the costs associated with preventative and control measures with adequate vaccine su
pply.

ASEAN Rabies Veterinary Vaccines Market Report Highlights

  • The companion animals segment is expected to expand at the highest CAGR over the forecast period owing to the large disease prevalence and risk rate among dogs, coupled with the rising dog vaccination program initiatives
  • Thailand is expected to dominate the market over the forecast period owing to the vaccination and surveillance strategies constantly executed by the country’s government to control rabies
  • Cambodia is anticipated to expand at the fastest CAGR over the forecast period owing to the country’s commitment to ‘rabies eradication by 2030’ programs and mass vaccination campaigns that recently gained traction in the country


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Country Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources & Third-Party Perspectives
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information/Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Approach 1: Commodity Flow Analysis
1.6.1.1 Hybrid Market Estimation Model
1.6.2 ASEAN Market: Cagr Calculation
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 ASEAN Rabies Veterinary Vaccines Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration And Growth Prospect Mapping, By Application, 2022
3.3 ASEAN Rabies Veterinary Vaccines Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.4 Estimated Animal Population, 2018 - 2022, By Key Countries
3.5 ASEAN Estimated Rabies Patient Volumes, By Region & Key Countries
3.6 ASEAN Estimated Spread Rate (Coverage) Of Rabies Vaccination, By Region & Key Countries
3.7 ASEAN Estimated Rabies Mortality Rate, By Region
3.8 Regulatory Framework
3.9 Covid-19 Impact Analysis
Chapter 4 ASEAN Rabies Veterinary Vaccines Market: By Application Analysis, 2018 - 2030 (USD Million)
4.1 Application Movement Analysis, 2018 - 2030 (USD Million)
4.2 ASEAN Rabies Veterinary Vaccines Market Share Analysis, 2022 & 2030
4.3 Companion Animals
4.3.1 Companion Animals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4 Livestock Animals
4.4.1 Livestock Animals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5 ASEAN Rabies Veterinary Vaccines Market: Country Market Analysis, By Application 2018 - 2030 (USD Million)
5.1 Country Market Share Analysis, 2022 & 2030
5.2 ASEAN
5.2.1 ASEAN Rabies Veterinary Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.2.2 Thailand
5.2.2.1 Thailand Rabies Veterinary Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.2.3 Vietnam
5.2.3.1 Vietnam Rabies Veterinary Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.2.4 Cambodia
5.2.4.1 Cambodia Rabies Veterinary Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.2.5 Indonesia
5.2.5.1 Indonesia Rabies Veterinary Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.2.6 Laos
5.2.6.1 Laos Rabies Veterinary Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.2.7 Malaysia
5.2.7.1 Malaysia Rabies Veterinary Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.2.8 Philippines
5.2.8.1 Philippines Rabies Veterinary Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.2.9 Myanmar
5.2.9.1 Myanmar Rabies Veterinary Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.10 Rest of ASEAN
5.2.10.1 Rest of ASEAN Rabies Veterinary Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6 ASEAN Rabies Veterinary Vaccines Market - Competitive Landscape
6.1 List of Key Companies
6.1.1 Merck & Co., Inc.
6.1.2 Boehringer Ingelheim International GmbH
6.1.3 Indian Immunologicals Ltd.
6.1.4 Zoetis
6.1.5 Virbac
6.1.6 BroadChem Philippines Biopharma Corporation
6.2 Participant’s Overview
6.3 Financial Performance
6.4 Participant Categorization
6.4.1 Market Leaders
6.4.2 Strategy Mapping
List of Tables
Table 1 List of secondary sources
Table 2 List of Key companies
Table 3 ASEAN rabies veterinary vaccines market by country, 2018 - 2030 (USD Million)
Table 4 ASEAN rabies veterinary vaccines market by application, 2018 - 2030 (USD Million)
Table 5 Thailand rabies veterinary vaccines market by application, 2018 - 2030 (USD Million)
Table 6 Vietnam rabies veterinary vaccines market by application, 2018 - 2030 (USD Million)
Table 7 Cambodia rabies veterinary vaccines market by application, 2018 - 2030 (USD Million)
Table 8 Indonesia rabies veterinary vaccines market by application, 2018 - 2030 (USD Million)
Table 9 Laos rabies veterinary vaccines market by application, 2018 - 2030 (USD Million)
Table 10 Malaysia rabies veterinary vaccines market by application, 2018 - 2030 (USD Million)
Table 11 Philippines rabies veterinary vaccines market by application, 2018 - 2030 (USD Million)
Table 12 Myanmar rabies veterinary vaccines market by application, 2018 - 2030 (USD Million)
Table 13 Rest of ASEAN rabies veterinary vaccines market by application, 2018 - 2030 (USD Million)
List of Figures
FIG. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 General methodology for commodity flow analysis of animal health market
Fig. 9 Market formulation & validation
Fig. 10 Commodity flow analysis
Fig. 11 Parent market analysis
Fig. 12 Market snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Competitive landscape snapshot
Fig. 16 Parent market outlook
Fig. 17 Ancillary market outlook
Fig. 18 Penetration & growth prospect mapping by product, 2022
Fig. 19 Market trends & outlook
Fig. 20 Market driver relevance analysis (Current & future impact)
Fig. 21 Market restraint relevance analysis (Current & future impact)
Fig. 22 ASEAN rabies veterinary vaccines market application outlook: market share analysis, 2022 & 2030
Fig. 23 ASEAN rabies veterinary vaccines market: application movement analysis
Fig. 24 Companion animals market 2018 - 2030 (USD Million)
Fig. 25 Livestock animals market 2018 - 2030 (USD Million)
Fig. 26 ASEAN outlook, 2022 & 2030
Fig. 27 ASEAN rabies veterinary vaccines market by countries, 2018 - 2030 (USD Million)
Fig. 28 Thailand market, 2018 - 2030 (USD Million)
Fig. 29 Vietnam market, 2018 - 2030 (USD Million)
Fig. 30 Cambodia market, 2018 - 2030 (USD Million)
Fig. 31 Indonesia market, 2018 - 2030 (USD Million)
Fig. 32 Laos market, 2018 - 2030 (USD Million)
Fig. 33 Malaysia market, 2018 - 2030 (USD Million)
Fig. 34 Philippines market, 2018 - 2030 (USD Million)
Fig. 35 Myanmar market, 2018 - 2030 (USD Million)
Fig. 36 Rest of ASEAN market, 2018 - 2030 (USD Million)
Fig. 37 Market participant categorization
Fig. 38 Company market position analysis
Fig. 39 Major deals & strategic alliances analysis

Companies Mentioned

  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Indian Immunologicals Ltd.
  • Zoetis
  • Virbac
  • BroadChem Philippines Biopharma Corporation

Methodology

Loading
LOADING...

Table Information